Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Appointed director

10x Genomics, Inc. (TXG) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/24/2023 4 Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 3,757 shares @ $45.7811, valued at $172k
08/24/2023 4 McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 1,678 shares @ $45.7811, valued at $76.8k
08/24/2023 4 Wilbur James (Chief Commercial Officer) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 9,699 shares @ $45.7811, valued at $444k
08/24/2023 4 Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 3,449 shares @ $45.7811, valued at $157.9k
08/16/2023 4 Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 1,983 shares @ $50.1033, valued at $99.4k
Sold 17 shares @ $50.42, valued at $857.1
08/03/2023 4 Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 1,727 shares @ $61.7714, valued at $106.7k
Sold 5,243 shares @ $62.3561, valued at $326.9k
Exercised 6,970 options to buy @ $11.48, valued at $80k
08/03/2023 8-K Quarterly results
Docs: "10x Genomics Reports Second Quarter 2023 Financial Results"
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/21/2023 144 Form 144 - Report of proposed sale of securities:
07/20/2023 8-K Quarterly results
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/10/2023 SC 13G/A MORGAN STANLEY reports a 5.2% stake in 10x Genomics, Inc.
07/10/2023 SC 13G/A FMR LLC reports a 12.7% stake in 10X GENOMICS INC
06/16/2023 4 ROBERTS BRYAN E (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/16/2023 4 SULIMAN SHEHNAAZ (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/16/2023 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/16/2023 4 Popovits Kimberly J (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/16/2023 4 Mammen Mathai (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/16/2023 4 Kosaraju Sridhar (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Granted 1,865 shares @ $0
Granted 4,661 options to buy @ $57.62, valued at $268.6k
06/16/2023 4 Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns: Gifted 185 shares @ $0
Sold 740 shares @ $57.5038, valued at $42.6k
Sold 1,209 shares @ $58.5262, valued at $70.8k
Sold 51 shares @ $59.15, valued at $3k
06/16/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/07/2023 4 STUELPNAGEL JOHN R (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 10,000 shares @ $54.8894, valued at $548.9k
05/25/2023 4 Hindson Benjamin J. (See Remarks) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 243 shares @ $55.0594, valued at $13.4k
Sold 619 shares @ $55.0605, valued at $34.1k
Sold 735 shares @ $55.0631, valued at $40.5k
Sold 791 shares @ $55.0612, valued at $43.6k
05/25/2023 4 Wilbur James (Chief Commercial Officer) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 316 shares @ $55.0653, valued at $17.4k
05/25/2023 4 McAnear Justin J. (CFO) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 194 shares @ $55.0695, valued at $10.7k
Sold 465 shares @ $55.0621, valued at $25.6k
Sold 441 shares @ $55.0641, valued at $24.3k
Sold 565 shares @ $55.0637, valued at $31.1k
05/23/2023 4 Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns: Gifted 460 shares @ $0
Sold 534 shares @ $55.064, valued at $29.4k
Sold 2,068 shares @ $55.0613, valued at $113.9k
05/19/2023 4 ROBERTS BRYAN E (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Converted 3,790,422 shares @ $0
Converted 3,790,422 options to buy @ $0
05/17/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "10x Genomics Wins Permanent Injunction Against NanoString’s CosMx Products 10x Genomics is seeking additional injunctions to protect its intellectual property"
05/17/2023 4 Saxonov Serge (CEO) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 494 shares @ $52.6971, valued at $26k
Sold 1,506 shares @ $53.5652, valued at $80.7k
05/15/2023 4 Mammen Mathai (Director) has filed a Form 4 on 10x Genomics, Inc.
Txns: Sold 33,000 shares @ $52.8208, valued at $1.7M
Exercised 200,000 options to buy @ $1.16, valued at $232k
05/11/2023 144 Form 144 - Report of proposed sale of securities:
05/04/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy